COCP

Cocrystal Pharma, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 4/30/2017
Contact Info
  • 1860 Montreal Road
  • Tucker, GA 30084

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001412486
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2006
Employees Not Available
Company Officers/Contacts
Gary Wilcox Interim CEO
Sam Lee President
James J. Martin CFO
Company Directors
Raymond Schinazi Chairman
Gary Wilcox Chairman
David Block
Phillip Frost
Jane H. Hsiao
Steve Rubin
Company Notes
  • Domicile change from Nevada to Delaware
  • Formerly=Biozone Pharmaceuticals, Inc. until 4-2014
  • Formerly=International Surf Resorts, Inc. until 3-2011
Service Providers
Accounting/Auditing Firm
BDO USA, LLP
945 E Park Drive
Suite 103
Harrisburg, PA, 17111
United States

Legal Counsel
Nason, Yeager, Gerson, White & Lioce P.A.
3001 PGA Boulevard, Suite 305
Palm Beach Gardens, FL, 33410
United States

Investor Relations Firm
Not Available
COCP Security Details
Share Structure
Market Value1 $207,061,486 a/o Sep 18, 2017
Authorized Shares 800,000,000 a/o Sep 07, 2017
Outstanding Shares 726,531,530 a/o Sep 07, 2017
-Restricted 633,789,511 a/o Sep 07, 2017
-Unrestricted 92,742,019 a/o Sep 07, 2017
Held at DTC 91,865,023 a/o Sep 07, 2017
Float 86,561,000 a/o Apr 29, 2015
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Equity Stock Transfer
Shareholders
Shareholders of Record 232 a/o Mar 31, 2017
Short Selling Data
Short Interest 1,805,913 (-16.57%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security